Or Akiva, Israel

Nissm Sasson

This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2008.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nissm Sasson: Innovator in Pharmaceutical Chemistry

Introduction

Nissm Sasson is a notable inventor based in Or Akiva, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that are essential for various medical applications. His work has led to the creation of a patent that addresses important aspects of drug formulation.

Latest Patents

Nissm Sasson holds a patent for "Risedronate sodium having a very low content of iron." This invention relates to a method of making risedronate sodium substantially free of iron. The process involves refluxing a combination of risedronic acid, a sodium base, and an iron-reducing amount of EDTA in a suitable liquid medium. The result is the isolation of risedronate sodium that is substantially free of iron, which is crucial for ensuring the efficacy and safety of the drug.

Career Highlights

Nissm Sasson is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative solutions that enhance drug formulations and improve patient outcomes. His expertise in pharmaceutical chemistry has been instrumental in advancing the company's research and development efforts.

Collaborations

Nissm has collaborated with several talented professionals in his field, including Revital Lifshitz-Liron and Ramiy Lidor-Hadas. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking pharmaceutical solutions.

Conclusion

Nissm Sasson's contributions to pharmaceutical chemistry, particularly through his patent on risedronate sodium, highlight his innovative spirit and dedication to improving drug formulations. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…